Influential Brazil-based research organization, Hcor, is using Oracle Clinical One Data Collection to build its critical phase 3 immunology studies. Prior to Oracle, Hcor had relied on third-party firms to build studies, adding time and complexity to the process. With Oracle’s modern, intuitive cloud-based data collection solution, Hcor is now able to build and manage its studies independently, helping to reduce costs, and accelerate trial execution.

Built on the security, performance, and scalability of Oracle Cloud Infrastructure, Oracle Clinical One Data Collection is part of Oracle’s broad portfolio of life sciences solutions.

“Hcor is dedicated to delivering the best healthcare possible, and technology plays a crucial role in achieving that goal,” said Tamiris Abait Miranda, research institute manager, Hcor. “With Oracle Clinical One Data Collection, we have built two important immunology trials independently using Oracle’s robust and reliable platform, which can help to accelerate potentially life-changing clinical trials.”

Hcor is a Brazilian hospital specializing in cardiology, oncology and other areas of health. It is renowned for being an innovative research institute and its involvement in clinical trials.

Reducing trial cost and complexity

Oracle Clinical One Data Collection offers a modern approach to electronic data capture, enabling life sciences organizations to collect datasets from diverse sources and unlock valuable clinical insights.

Oracle was recognized as a leader for this comprehensive approach in the latest Everest Group PEAK Matrix for electronic data capture. The data platform’s intuitive, user-friendly design makes it easy to execute study builds and real-time, mid-study adjustments without sacrificing quality or the need for costly intervention from third-party vendors or programmers. This can help accelerate the timeline of trial execution and reduce study build times.

“Our unified platform helps organizations like Hcor make it easier to build studies independently and have more flexibility and control throughout the entire trial lifecycle,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “This is part of our larger mission to help our customers leverage the latest in AI and cloud technology to drastically change how studies are conducted. By focusing on patient-centric solutions, connecting patients and trials at the point of care, enhancing safety monitoring, accelerating data collection, and expediting regulatory submissions, we aim to bring life-changing therapies to patients more rapidly.”

Hcor is also benefiting from the low latency and high computing power of Oracle Exadata Cloud@Customer. By moving its workloads and development platforms onto the Oracle Exadata Cloud@Customer, Hcor has also boosted its overall IT performance by 20%. Hcor’s developers are launching healthcare projects 5X faster than before, delivering fully tested applications in one month instead of five months. Additionally, the solution has significantly enhanced security and increased the number of projects that can be completed per month, reducing backlog, and accelerating patient care initiatives. Read more here.

For more information about Oracle Clinical One Data Collection solution please visit: https://www.oracle.com/life-sciences/clinical-trials/data-collection/